• 800 343 7475ir@bio-techne.com bio-techne.com

    • Overview
    • News / Events
    • Company Information
    • Strategy
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    Navigation

      News / Events

    • Overview
    • News / Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Profile
      • Presentations
      • Management Team
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Balance Sheet
      • Income Statement
      • Cash Flow
      • Financial Results
      • Annual Reports
    • Stock Data
      • Overview
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • 10-K Filings
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents

    Press Releases

    • News / Events

    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
    Jul 5, 2022

    BIO-TECHNE ANNOUNCES COMPLETION OF NAMOCELL ACQUISITION

    Jun 22, 2022

    BIO-TECHNE TO ACQUIRE NAMOCELL

    May 26, 2022

    Bio-Techne Celebrates 40,000 Unique RNAscope™ in situ Hybridization Probes, Targeting Any Gene, Any Tissue, Any Species.

    May 25, 2022

    GLOBAL STUDY DEMONSTRATES ICE3 AND MAURICE CAPILLARY ISOELECTRIC FOCUSING COMPARABILITY IN THE JOURNAL OF ELECTROPHORESIS

    May 19, 2022

    BIO-TECHNE TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE

    May 12, 2022

    Bio-Techne and Nonagen Bioscience Announce Exclusive Supply Agreement for Nonagen's Oncuria® Bladder Cancer Test

    May 10, 2022

    BIO-TECHNE TO PRESENT AT ANNUAL AMERICAN UROLOGICAL ASSOCIATION CONFERENCE IN NEW ORLEANS

    May 4, 2022

    BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2022 RESULTS

    May 4, 2022

    BIO-TECHNE DECLARES DIVIDEND

    May 2, 2022

    BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTHCARE CONFERENCE

    RSS
    • 1...
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    • 23
    • ...49
    • Email Alerts
    • Contacts
    • RSS News Feed
    Bio-Techne

    614 McKinley Place NE
    Minneapolis, MN 55413
    USA

    TEL 612 379 2956
    Toll-free 800 343 7475
    FAX 612 656 4400

    Who We Are

    • About Bio-Techne
    • Bio-Techne Brands
    • Careers
    • Corporate & Social Responsibility
    • Terms and Conditions

    Investor Relations

    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance

    Stay Connected

    • Facebook Twitter LinkedIn YouTube Instagram
    • Contact Us

    Utility Footer Menu

    • Privacy and Cookie Policy
    • Site Map
    • © Copyright 2025 Bio-Techne. All Rights Reserved.